Lymphoma Risk in RA Patients Remains Steady
Fellows’ Forum Case Report: Hemophagocytic Lymphohistiocytosis
Malignancy Risk in ANCA-Associated Vasculitis Is Lower with Rituximab
Tofacitinib Not Tied to More Malignancies in RA Patients
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
ACR Convergence
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
Meeting Abstracts
Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.